Drug Compounding Bill to Clarify the FDA's Role, Introduce New Regulatory Limits

Congress has passed a new law clarifying the relationship between the U.S. Food and Drug Administration (FDA) and pharmacy compounding facilities. The text of the bill as introduced in the Senate and was passed by voice vote without substantive changes.

Read More: Drug Compounding Bill to Clarify the FDA's Role, Introduce New Regulatory Limits


Download PDF Share Back To Listing
Loading data